Emergent COVID-19 Vaccine Plant’s Quality Issues Draw Unusual Spotlight From US FDA Topsiders

Emergent BioSolutions
some improvising was going on in overcrowded plant • Source: Alamy

More from Vaccines

More from Pink Sheet